The research

The programs that we cofinance

We select the programs that we cofinance with the help of the researchers and notably the ITCC* with whom we signed a partnership in 2012. Our strategy is to finance the programs that are the most innovating, with the highest success factor and that will benefit the largest number of children.

* Innovative Therapies for Children with Cancer


It means finding the “weakness” of the tumor in order to target the best possible treatment, by analyzing the complete sequencing of tumors or leukemia. It also consists in analyzing all the available data in order to better understand childhood cancer.


It means proposing better adapted, better targeted and therefore more effective therapies. Some of the programs that we finance offer treatments that are particularly innovative, such as immunotherapy.

Launching call for innovative projects

Boosting research in Europe and channelling the funds raised to the most impactful programmes: this is the ambition of the Fight Kids Cancer project call, which we launched on 15 January…

BIOMEDE presented for the 1st time at the SNO annual congress

The BIOMEDE study shows the importance of sequencing children brain tumor at diagnosis. Presented for the first time in November 2019 in the United States, the first results of the major…

MAPPYACTS enables precision medecine for children with therapeutic failure

Presented at the ASCO annual congress in Chicago in June 2019, the first results of MAPPYACTS, that we have cofunded giving 1.720.000€ thanks to the Children without Cancer races in…

Conventions and conferences

Conventions and conferences

Conventions and conferences

Understand, analyze, testify, exchange, propose, enlist: being on all the fronts to defend our cause and accelerate the decision process and the action in favor of research. Since the creation of the association, we participate in the main conventions and conferences on pediatric cancers in France and internationally.

Enlist the research stakeholders

Enlist the research stakeholders

Enlist the research stakeholders

Beyond the financial assistance that we bring to the researchers, we enlist and unite the research stakeholders in France and Europe so that childhood cancer becomes a priority for all.
Every year in February, we organize a seminar at the French Senate to bring together the research players in France.

6th edition of the FAST seminar

18 February 2020

Our scientific partners

Gustave Roussy
Institut Curie

Words that move us

“The Imagine for Margo association has helped place childhood cancer on the European agenda. Thanks to Imagine for Margo, we are gaining time and we are implementing tests that would not have started for lack of funding.”

Professor Gilles VASSAL, Director of Research at Gustave Roussy

“I would like to thank you for bringing us together again and again for this cause and to remind us what we are striving for. Because at the end, it's the patients that we want to help and in this sense your support is very helpful."

Dr. Stefan Pfister, Chair of the Biology Committee at ITCC

“Imagine for Margo provides huge support in backing our projects financially, in a significant and constant manner. This allows us to move forward faster in our research”

Birgit Geoerger, researcher at Gustave Roussy, director of the MAPPYACTS and ESMART programs

“The work that the association does to bring together, at the same time, researchers, clinicians, laboratories, pharmaceuticals, the families, is really something extremely important. The financial help is of course very important, but what Imagine for Margo brings goes beyond that.”

Gudrun Schleiermacher, researcher at the Curie Institute, director of the MICCHADO program